GLOBAL ANATOMIX, LLC – Trademark Portfolio
Entity Type: 16
GLOBAL ANATOMIX, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GAX-SPECIMEN and ANATOMY BROUGHT TO LIFE. The owner is based in GARLAND, TX.
5435 N. GARLAND AVE., SUITE 140, #172
GARLAND, TX 75040
Showing of trademarks Trademarks
Trademark Classifications
GLOBAL ANATOMIX, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does GLOBAL ANATOMIX, LLC have?
GLOBAL ANATOMIX, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does GLOBAL ANATOMIX, LLC file in?
GLOBAL ANATOMIX, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are GLOBAL ANATOMIX, LLC's most well-known trademarks?
GLOBAL ANATOMIX, LLC's registered trademark portfolio includes well-known marks such as GAX-SPECIMEN and ANATOMY BROUGHT TO LIFE. These are among 2 currently registered trademarks in the portfolio.
What is GLOBAL ANATOMIX, LLC's trademark registration success rate?
GLOBAL ANATOMIX, LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.